179 related articles for article (PubMed ID: 30866863)
1. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
[TBL] [Abstract][Full Text] [Related]
2. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
3. Reversal of liver cancer-associated stellate cell-induced stem-like characteristics in SMMC-7721 cells by 8-bromo-7-methoxychrysin via inhibiting STAT3 activation.
Cui Y; Sun S; Ren K; Quan M; Song Z; Zou H; Li D; Cao J
Oncol Rep; 2016 May; 35(5):2952-62. PubMed ID: 26935885
[TBL] [Abstract][Full Text] [Related]
4. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1.
Chen A; Xu C; Luo Y; Liu L; Song K; Deng G; Yang M; Cao J; Yuan L; Li X
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1267-1275. PubMed ID: 31750892
[TBL] [Abstract][Full Text] [Related]
5. 8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells.
Luo Y; Cui Y; Cao X; Li X; Chen A; Zhang J; Chen X; Cao J
Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):458-464. PubMed ID: 28369327
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line.
Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y
Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522
[TBL] [Abstract][Full Text] [Related]
7. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma.
Yu G; Jing Y; Kou X; Ye F; Gao L; Fan Q; Yang Y; Zhao Q; Li R; Wu M; Wei L
PLoS One; 2013; 8(9):e73312. PubMed ID: 24023859
[TBL] [Abstract][Full Text] [Related]
9. 8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells.
Sun S; Cui Y; Ren K; Quan M; Song Z; Zou H; Li D; Zheng Y; Cao J
Anticancer Agents Med Chem; 2017; 17(2):286-293. PubMed ID: 26845136
[TBL] [Abstract][Full Text] [Related]
10. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells.
Cao X; Zou H; Cao J; Cui Y; Sun S; Ren K; Song Z; Li D; Quan M
BMC Complement Altern Med; 2016 Sep; 16():364. PubMed ID: 27633248
[TBL] [Abstract][Full Text] [Related]
11. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK.
Yang XH; Zheng X; Cao JG; Xiang HL; Liu F; Lv Y
World J Gastroenterol; 2010 Jul; 16(27):3385-93. PubMed ID: 20632440
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.
Iwahasi S; Rui F; Morine Y; Yamada S; Saito YU; Ikemoto T; Imura S; Shimada M
Anticancer Res; 2020 Feb; 40(2):743-749. PubMed ID: 32014916
[TBL] [Abstract][Full Text] [Related]
13. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
[TBL] [Abstract][Full Text] [Related]
14. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
[TBL] [Abstract][Full Text] [Related]
15. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
16. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
Ma T; Wang Z; Yang Z; Chen J
Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
[TBL] [Abstract][Full Text] [Related]
18. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
